All of the animal studies were conducted on diabetic rats, including three studies on type 1 diabetic rats and six studies on type 2 [17,18,19,20,21,22,23,24,25]
Increase IGF-1 Levels in as little as two weeks longer REM sleep and shorter sleep latency Increase fat-free muscle mass Decrease body fat percentage Stronger bones Improved endurance Increase nitrogen levels in the body Reversal of nitrogen wasting MOTS-C MOTS-c is a peptide encoded as an sORF in the mtDNA that is metabolically and developmentally regulated, which has endocrine-like effects on muscle metabolism, insulin sensitivity, and weight regulation establishes its role as a member of a new class of mitochondrial signals which can be called MDPs (Lee et al., 2013)
Skyrocketing sales for weight loss drugs known as GLP-1s, first made popular via the diabetes treatment Ozempic, have had ripple effects across the global economy
(4) Standard therapy combines atropine, which antagonizes muscarinic receptor overstimulation, with pralidoxime (2-PAM), which reactivates uninhibited or non-aged AChE
Clinical studies and meta-analyses have identified an increased risk of gallbladder disease with GLP-1 receptor agonist use, particularly with weight loss medications
Sam Hawley: Okay, well, let's come a bit more to the risks in a moment